Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.

Saved in:
Bibliographic Details
Title: Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Authors: Krishnan M; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA. mridula.krishnan@unmc.edu., Bociek RG; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Fanale M; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Iyer SP; Department of Lymphoma/Multiple Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Lechowicz MJ; Department of Hematology, Emory University, Atlanta, GA, USA., Bierman PJ; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Armitage JO; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Lunning M; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Kallam A; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Vose JM; Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Source: Annals of hematology [Ann Hematol] 2022 Feb; Vol. 101 (2), pp. 335-340. Date of Electronic Publication: 2021 Oct 20.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-021-04692-9